Zobrazeno 1 - 5
of 5
pro vyhledávání: '"M A, Chattergoon"'
Autor:
J J, Kim, N N, Trivedi, D M, Wilson, S, Mahalingam, L, Morrison, A, Tsai, M A, Chattergoon, K, Dang, M, Patel, L, Ahn, J D, Boyer, A A, Chalian, H, Schoemaker, T, Kieber-Emmons, M A, Agadjanyan, D B, Weiner, H, Shoemaker
Publikováno v:
Oncogene. 17:3125-3135
Nucleic acid immunization has been investigated as immunotherapy for infectious diseases as well as for treating specific types of cancers. In this approach, nucleic acid expression cassettes are directly inoculated into the host, whose transfected c
Publikováno v:
The Journal of Immunology. 158:816-826
Recent studies support the importance of investigating a DNA vaccination approach for the immunologic control of HIV-1. In this regard, it may be important to specifically engineer immune responses in order to improve on first generation vaccine atte
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 160(12)
The initiation of an adaptive immune response requires Ag presentation in combination with the appropriate activation signals. Classically, Ag presentation and immune activation occur in the lymph node and spleen, where a favorable organ architecture
Autor:
J J, Kim, N N, Trivedi, L K, Nottingham, L, Morrison, A, Tsai, Y, Hu, S, Mahalingam, K, Dang, L, Ahn, N K, Doyle, D M, Wilson, M A, Chattergoon, A A, Chalian, J D, Boyer, M G, Agadjanyan, D B, Weiner
Publikováno v:
European journal of immunology. 28(3)
Immunization with nucleic acids has been shown to induce both antigen-specific cellular and humoral immune responses in vivo. We hypothesize that immunization with DNA could be enhanced by directing specific immune responses induced by the vaccine ba
Autor:
J J, Kim, V, Ayyavoo, M L, Bagarazzi, M A, Chattergoon, K, Dang, B, Wang, J D, Boyer, D B, Weiner
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 158(2)
Recent studies support the importance of investigating a DNA vaccination approach for the immunologic control of HIV-1. In this regard, it may be important to specifically engineer immune responses in order to improve on first generation vaccine atte